info@lightchainbio.com
+41 22 552 72 00
Find us
Join our team to invent new therapies and help patients.
Bispecific antibody programs
Multispecific antibody programs
Monoclonal antibody programs
Back
Don't miss any career opportunities and follow us now on LinkedIn
Written by Mei Liang Belhumeur on Tuesday, 12 December 2023. Posted in News
Structural analysis of light chain-driven bispecific antibodies targeting CD47 andPD-L1
Read more